tirzepatide and statins 🧠Let's break the drug down using this mnemonic cloud!⁠ ⁠ 💉 Tirzepatide is a GLP-1 GIP agonist. ⁠ ⁠ 🤔But what exactly is glucagon-like peptide (GLP-1) and gastric inhibitory polypeptide (GIP)? ⁠ ⁠ Tirzepatide goes beyond weight loss—supporting

Chronic kidney disease

STEP UP Phase 3 Trial Design The sNDA incorporates data from the STEP UP trial (NCT05646706), a 72-week, randomized, double-blind, placebo- and active-controlled superiority study involving 1,407 adults with obesity (BMI 30 kg/m)

Strategic pre-injection nutrition directly reduces nausea, bloating, constipation, and digestive discomfortthe most common early side effects

However, this effect was not seen in other major cardiovascular outcome trials (CVOTs) and their blood pressure lowering effect remains controversial, which will be further discussed below

In this episode of STATus Report, host Alex Hogan takes a look at the state of this research, and talks to addiction reporter Lev Facher and physician Steven Klein, who is already prescribing GLP-1s to his addiction patients

Checkout-first intake review and pharmacy-controlled dispensing place oversight with clinicians and licensed pharmacies, not with the SkinnyRx platform